Article
Unveiling a Potential Prognostic Biomarker in KRAS-Mutant Lung Adenocarcinoma Using Weighted Gene Co-Expression Network Analysis
2023-08-02
Abstract excerpt
<h4>Background</h4> Globally, lung cancer is the leading cause of cancer-related deaths, primarily non-small cell lung cancer (NSCLC). Kirsten Rat Sarcoma Oncogene Homolog (KRAS) mutations are common in NSCLC and linked to a poor prognosis. Covalent inhibitors targeting KRAS-G12C mutation have improved treatment for some patients, but most KRAS-mutant lung adenocarcinoma (KRAS-MT LUAD) cases lack targeted therapi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e20f437f-96de-57f1-8d13-5b730dc5d7f1
- DOI
- 10.1101/2023.07.31.551246
